During the assessment period (2022-2032), demand in the global Venous Stents market is anticipated to grow at an 8.5% CAGR. According to Fact.MR, the market’s total sales are anticipated to be worth US$2.44 billion by the year 2032.
Stents are typically crushed and delivered to their target area using a venous catheter. Some catheters need a blown-up balloon to help them expand, while others do it on their own. By expanding against them, these stents keep the narrowed or obstructed veins open.
According to this thorough market analysis by Fact.MR, a supplier of market research and competitive intelligence, the global venous stents market is presently valued at US$1.08 billion and is anticipated to grow quickly between 2022 and 2032 at a CAGR of 8.5%.
Both central and peripheral veins’ vascular walls are supported by these flexible implants. Typically, surgeons install venous stents in larger, main veins including those in the legs, abdomen, and chest.
Download A Sample Copy of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7879?AS
Metal mesh tubes called venous stents treat chronic blood clots and other conditions. They serve as a support structure to keep veins open. Venous stents are typically implanted by surgeons in larger, major veins, such as those in the legs, chest, and abdomen.
They are flexible tools that support the vascular walls in both peripheral and central veins. The key factors anticipated to boost the demand for venous stents during the projected period include the development of numerous effective technologies for the accurate positioning of stents in veins and an increase in key players’ investments in the advancement of flexible venous stents with potential radial strength.
North America currently dominates the global venous stents market. Followed by North America, Europe leads the sales of venous stents. The vast pool of patients who require venous stent implantation due to several heart-related disorders is anticipated to boost the sales of venous stents in Europe.
Furthermore, the region’s market is projected to grow as a result of the presence of numerous top venous stent manufacturers as well as a developing healthcare industry.
Another region that is quickly rising to prominence in the market for venous stents is Asia Pacific. The market is developing as a result of increased investments in healthcare infrastructure and treatment standards by several countries in the region.
Key Takeaways from Market Study
- The global market for venous stent devices is projected to reach US$ 2.44 billion by 2032.
- Germany’s market is predicted to expand at a CAGR of 7% during the forecast period.
- Demand for venous stents in China is expected to rise at an impressive CAGR of 12% during the forecast period.
- Revenue from Wallstent technologies is expected to increase at a high CAGR of 9% during the next 10 years.
Key Companies Profiled by Fact.MR
- Becton, Dickinson Company
- Boston Scientific Corporation
- Cook Medical LLC
- Gore Medical
- Jotec GmbH
- OptiMed Medizinische Instrumente GmbH
Winning Strategy
To increase their market share, top companies are focusing on developing technologically sophisticated venous stent devices. The technological and functional developments in venous stents boost sales growth.
- The Pulsar-18 T3 peripheral self-expanding stent system from BIOTRONIK was approved by the U.S. Food and Drug Administration (FDA) in July 2021 for a better implantation method during endovascular procedures.
Key Segments of Venous Stents Industry Research
- By Application:
- Leg
- Chest
- Abdomen
- Arm
- By Disease Indication:
- Chronic Deep Vein Thrombosis
- Post Thrombotic Syndrome
- May-Thurner Syndrome
- Hemodialysis/Arteriovenous Fistulae
- By Technology:
- Iliac Vein Stent Technologies
- Wallstent Technologies
- By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global venous stents market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2032.
The study divulges essential insights on the market on the basis of application (leg, chest, abdomen, arm), disease indication (chronic deep vein thrombosis, post thrombotic syndrome, May-Thurner syndrome, hemodialysis/arteriovenous fistulae), and technology (Iliac vein stent technologies, Wallstent technologies), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7879?AS
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Email : [email protected]